Cargando…
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
BACKGROUND: Hallmarks of CNS inflammation, including microglial and astrocyte activation, are prominent features in post-mortem tissue from amyotrophic lateral sclerosis (ALS) patients and in mice overexpressing mutant superoxide dismutase-1 (SOD1(G93A)). Administration of non-targeted glucocorticoi...
Autores principales: | Evans, Matthew C, Gaillard, Pieter J, de Boer, Marco, Appeldoorn, Chantal, Dorland, Rick, Sibson, Nicola R, Turner, Martin R, Anthony, Daniel C, Stolp, Helen B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229735/ https://www.ncbi.nlm.nih.gov/pubmed/24923195 http://dx.doi.org/10.1186/2051-5960-2-66 |
Ejemplares similares
-
The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2015) -
What Does Imaging Reveal About the Pathology of Amyotrophic Lateral Sclerosis?
por: Turner, Martin R., et al.
Publicado: (2015) -
Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation
por: Forsberg, Karin M., et al.
Publicado: (2022) -
The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
por: Gaur, Nayana, et al.
Publicado: (2020) -
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
por: Tefera, Tesfaye Wolde, et al.
Publicado: (2021)